Skip to main content
Clinical Trials/NCT06475222
NCT06475222CompletedNot Applicable

Development and Effectiveness Evaluation of Facial Serum and Mask and Ready-to-drink Jelly From Thai Rice (Oryza Sativa L.)

Burapha University2 sites in 1 country104 target enrollmentStarted: September 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
104
Locations
2
Primary Endpoint
Concentration of interferon-gamma

Study Overview

Brief Summary

This study consisted of three sub-studies including 1) development and evaluation of facial serum from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants 2) development and evaluation of facial mask from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants and 3) development and evaluation of ready-to-drink jelly from Thai rice on controlling blood glucose and endurance time in healthy participants.

Detailed Description

Study 1: 30 male and female participants, age 30-50 years will be randomly applied with facial serum producing from either 2% alpha albutin (standard facial serum) or Tubtim Chumphae rice extract on either right side or left side of their face daily for 12 weeks.

Study 2: 60 male and female participants, age 30-50 years will be randomly assigned into 2 groups including 1) control group (n = 30): participants will not receive any facial mask for 12 weeks and 2) treatment group (n = 30): participants will be applied with home-based program facial mask with Hom Pathum rice extract for 30 min/day, 2 days/week for 12 weeks.

Study 3: this study consists of 2 sub-studies. Study 3.1: 25 male and female participants, age 18-35 years will be randomly consumed with control jelly, jelly with Tubtim Chumphae rice, and jelly with Hom Pathum rice at 3.5 g/kg body weight. All participants will be measured for blood glucose levels before consumption and after consumption at 30, 60, 90, and 120 min. Study 3.2: 25 male and female participants, age 18-35 years will be randomly consumed with control jelly, jelly with Tubtim Chumphae rice, and jelly with Hom Pathum rice at 3.5 g/kg body weight. After each consumption, all participants will perform walking or running on treadmill at intensity of 80% maximal heart rate to measure maximal oxygen consumption.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Male or female
  • Age between 18 to 50 years
  • Interested in facial serum with Thai rice extract or facial mask with Thai rice extract or jelly from with Thai rice

Exclusion Criteria

  • History of adverse effects from facial serum or mask application or jelly consumption
  • Skin allergy
  • Skin disorders
  • Skin wounds
  • History of allergy to Thai rice, particularly in Tubtim Chumpae and Hom Pathum
  • History of allergy to facial serum or mask, i.e., serum or mask from rice
  • History of allergy to gelatin
  • Signs or symptoms of fever or infection
  • Abnormal body mass index
  • Regular smokers or alcohol drinkers (>2 times per week)
  • Regular exerciser (>2 times per week or >150 min per week)
  • Regular intake of dietary supplements, i.e., vitamins, antioxidants
  • Hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer

Outcomes

Primary Outcomes

Concentration of interferon-gamma

Time Frame: Before and immediately after maximal oxygen consumption test

Study 3.2 determines concentration of interferon-gamma in serum in pg (picogram)/mL unit

Level of skin elasticity

Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

Studies 1 and 2 determine level of skin elasticity in arbitrary unit (no unit) using Multiprobe Adapter System with Cutometer® 580 probe.

Level of skin moisture

Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

Studies 1 and 2 determine level of skin moisture in arbitrary unit (no unit) using Multiprobe Adapter System with Corneometer® CM 825 probe.

Concentration of interleukin-10

Time Frame: Before and immediately after maximal oxygen consumption test

Study 3.2 determines concentration of interleukin-10 in serum in pg (picogram)/mL unit

Level of skin oiliness

Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

Studies 1 and 2 determine level of skin oiliness in arbitrary unit (no unit) using Multiprobe Adapter System with Sebumeter® SM 815 probe.

Level of skin melanin

Time Frame: Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

Studies 1 and 2 determine level of skin melanin in arbitrary unit (no unit) using Multiprobe Adapter System with Mexameter® MX18 probe.

Level of blood glucose

Time Frame: Before jelly consumption and after jelly consumption at 30, 60, 90, and 120 minutes

Study 3.1 determines level of blood glucose in mg/dL unit

Level of maximal oxygen consumption

Time Frame: After jelly consumption for 30 minutes

Study 3.2 determines level of maximal oxygen consumption in mL/kg/min unit by walking or running on treadmill at intensity of 80% maximal heart rate.

Concentration of tumor necrosis factor-alpha

Time Frame: Before and immediately after maximal oxygen consumption test

Study 3.2 determines concentration of tumor necrosis factor-alpha in serum in pg (picogram)/mL unit

Level of superoxide dismutase activity

Time Frame: Before and immediately after maximal oxygen consumption test

Study 3.2 determines level of superoxide dismutase activity in percentage (%) unit

Concentration of malondialdehyde

Time Frame: Before and immediately after maximal oxygen consumption test

Study 3.2 determines concentration of malondialdehyde in micromolar (uM) unit

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Piyapong Prasertsri

Associate Professor Dr.

Burapha University

Study Sites (2)

Loading locations...

Similar Trials

Facial Serum and Mask and Ready-to-drink... | Clinical Trial